U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Trieu Vuong (0001587074)
Mailing Address
4003 JIM BOWIE ROAD
AGOURA HILLS CA 91301
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
OXIGENE INC
Current Name:Oncotelic Therapeutics, Inc.		 0000908259 2020-03-26 officer: CHIEF EXECUTIVE OFFICER
Marina Biotech, Inc.
Current Name:Adhera Therapeutics, Inc.		 0000737207 2016-11-15 director, officer: Chairman of the Board
Sorrento Therapeutics, Inc. 0000850261 2013-09-09 director, officer: Chief Scientific Officer


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2025-01-31   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 63775.0000 93189560.0000 3 0000908259 Common Stock
A 2025-01-30   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 100003.0000 93125785.0000 2 0000908259 Common Stock
A 2025-01-29   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 183066.0000 93025782.0000 1 0000908259 Common Stock
A 2024-11-22   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 298499.0000 92842716.0000 1 0000908259 Common Stock
A 2024-08-23   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 500000.0000 92544217.0000 1 0000908259 Common Stock
A 2023-06-29   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 425000.0000 92044217.0000 1 0000908259 Common Stock
A 2023-06-28   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 75000.0000 91619217.0000 2 0000908259 Common Stock
A 2023-06-16   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 100000.0000 91544217.0000 1 0000908259 Common Stock
A 2023-06-14   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 400000.0000 91444217.0000 1 0000908259 Common Stock
A 2023-05-26   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 126888.0000 91044217.0000 1 0000908259 Common Stock
A 2023-05-02   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 100000.0000 90917329.0000 1 0000908259 Common Stock
A 2022-12-06   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 120000.0000 90558021.0000 1 0000908259 Common Stock
A 2022-11-22   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 70000.0000 90438021.0000 1 0000908259 Common Stock
A 2022-09-26   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 20000.0000 90368021.0000 1 0000908259 Common Stock
A 2022-08-25   Oncotelic Therapeutics, Inc. 4 P-Purchase --D 80000.0000 90348021.0000 1 0000908259 Common Stock
A 2021-09-03   Oncotelic Therapeutics, Inc. 4 A-Award --D 225000.0000 225000.0000 1 0000908259 Stock Options
A 2021-07-08   Oncotelic Therapeutics, Inc. 4 A-Award --D 259302.0000 90527323.0000 2 0000908259 Common Stock
A 2021-07-08   Oncotelic Therapeutics, Inc. 4 A-Award --D 513953.0000 513953.0000 8 0000908259 Stock Options
A 2021-03-31   Oncotelic Therapeutics, Inc. 4 C-Conversion --D 74455719.0000 90268021.0000 1 0000908259 Common Stock
A 2021-03-31   Oncotelic Therapeutics, Inc. 4 C-Conversion --I 13849161.0000 16780384.0000 3 0000908259 Common Stock
A 2021-03-31   Oncotelic Therapeutics, Inc. 4 C-Conversion --I 5672025.0000 6872529.0000 4 0000908259 Common Stock
D 2021-03-31   Oncotelic Therapeutics, Inc. 4 C-Conversion --D 74456.0000 0.0000 5 0000908259 Series A Convertible Preferred Stock
D 2021-03-31   Oncotelic Therapeutics, Inc. 4 C-Conversion --I 13849.0000 0.0000 6 0000908259 Series A Convertible Preferred Stock
D 2021-03-31   Oncotelic Therapeutics, Inc. 4 C-Conversion --I 5672.0000 0.0000 7 0000908259 Series A Convertible Preferred Stock
A 2020-11-19   MATEON THERAPEUTICS INC 4 P-Purchase --D 50500.0000 15812308.0000 1 0000908259 Common Stock
A 2020-03-26   MATEON THERAPEUTICS INC 4 P-Purchase --D 3000.0000 15761808.0000 1 0000908259 Common Stock
D 2018-10-01   Marina Biotech, Inc. 4 D-Return --D 500000.0000 612716.0000 1 0000737207 Common Stock
A 2018-04-16   Marina Biotech, Inc. 4 A-Award --D 2.2500 2.2500 1 0000737207 Series E Convertible Preferred Stock
A 2018-04-16   Marina Biotech, Inc. 4 A-Award --D 16875.0000 16875.0000 2 0000737207 Warrants to Purchase Common Stock
A 2018-04-16   Marina Biotech, Inc. 4 C-Conversion --D 34.5100 34.5100 3 0000737207 Series E Convertible Preferred Stock
A 2018-04-16   Marina Biotech, Inc. 4 C-Conversion --D 258825.0000 258825.0000 4 0000737207 Warrants to Purchase Common Stock
D 2018-04-16   Marina Biotech, Inc. 4 C-Conversion --D $0.0000 5 0000737207 5% Convertible Promissory Note
A 2018-04-16   Marina Biotech, Inc. 4 C-Conversion --D 114.6300 114.6300 6 0000737207 Series E Convertible Preferred Stock
A 2018-04-16   Marina Biotech, Inc. 4 C-Conversion --D 859725.0000 859725.0000 7 0000737207 Warrants to Purchase Common Stock
D 2018-04-16   Marina Biotech, Inc. 4 C-Conversion --D $0.0000 8 0000737207 5% Demand Line of Credit
A 2018-04-16   Marina Biotech, Inc. 4 C-Conversion --I 19.0000 19.0000 9 0000737207 Series E Convertible Preferred Stock
A 2018-04-16   Marina Biotech, Inc. 4 C-Conversion --I 142500.0000 142500.0000 10 0000737207 Warrants to Purchase Common Stock
D 2018-04-16   Marina Biotech, Inc. 4 C-Conversion --I $0.0000 11 0000737207 5% Demand Line of Credit
A 2018-04-16   Marina Biotech, Inc. 4 P-Purchase --I 162.5900 162.5900 12 0000737207 Series E Convertible Preferred Stock
A 2018-04-16   Marina Biotech, Inc. 4 P-Purchase --I 2564465.0000 2564465.0000 13 0000737207 Warrants to Purchase Common Stock
A 2018-01-03   Marina Biotech, Inc. 4 A-Award --D 3800.0000 3800.0000 1 0000737207 Options to purchase common stock
A 2017-06-30   Marina Biotech, Inc. 4 A-Award --D 473240.0000 1 0000737207 5% Convertible Promissory Note
A 2017-06-09   Marina Biotech, Inc. 4 P-Purchase --D 10000.0000 11127141.0000 1 0000737207 Common Stock
A 2017-06-08   Marina Biotech, Inc. 4 P-Purchase --D 20000.0000 11117141.0000 1 0000737207 Common Stock
A 2017-06-07   Marina Biotech, Inc. 4 P-Purchase --D 2500.0000 11097141.0000 2 0000737207 Common Stock
A 2017-02-06   Marina Biotech, Inc. 4 P-Purchase --I 862068.0000 862068.0000 1 0000737207 Common Stock
A 2017-01-03   Marina Biotech, Inc. 4 A-Award --D 81000.0000 81000.0000 1 0000737207 Options to purchase common stock
A 2016-11-15   Marina Biotech, Inc. 4 A-Award --D 11094641.0000 11094641.0000 1 0000737207 Common Stock
A 2016-11-15   Marina Biotech, Inc. 4 A-Award --I 23123558.0000 23123558.0000 2 0000737207 Common Stock
A 2016-11-15   Marina Biotech, Inc. 4 A-Award --I 5255354.0000 5255354.0000 3 0000737207 Common Stock
A 2013-10-29   Sorrento Therapeutics, Inc. 4 A-Award --D 36000.0000 36000.0000 1 0000850261 Stock Options
- -   Sorrento Therapeutics, Inc. 3 - --D 3006641.0000 1 0000850261 Common Stock
- -   Marina Biotech, Inc. 3 - --- 1 - -
- -   Marina Biotech, Inc. 4 - --D 11094641.0000 2 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 23123558.0000 3 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 5255354.0000 4 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 862068.0000 3 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 23123558.0000 4 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 5255354.0000 5 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --D 1928571.0000 6 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 862068.0000 2 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 23123558.0000 3 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 5255354.0000 4 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --D 1928571.0000 5 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 2312355.0000 2 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 525535.0000 3 0000737207 Common Stock
- -   Marina Biotech, Inc. 4 - --I 86207.0000 4 0000737207 Common Stock
- -   MATEON THERAPEUTICS INC 3 - --D 15758808.0000 1 0000908259 Common Stock
- -   MATEON THERAPEUTICS INC 3 - --I 2931223.0000 2 0000908259 Common Stock
- -   MATEON THERAPEUTICS INC 3 - --I 1200504.0000 3 0000908259 Common Stock
- -   MATEON THERAPEUTICS INC 3 - --D 4 0000908259 Series A Convertible Preferred Stock
- -   MATEON THERAPEUTICS INC 3 - --I 5 0000908259 Series A Convertible Preferred Stock
- -   MATEON THERAPEUTICS INC 3 - --I 6 0000908259 Series A Convertible Preferred Stock
- -   MATEON THERAPEUTICS INC 4 - --I 2931223.0000 2 0000908259 Common Stock
- -   MATEON THERAPEUTICS INC 4 - --I 1200504.0000 3 0000908259 Common Stock
- -   MATEON THERAPEUTICS INC 4 - --I 2931223.0000 2 0000908259 Common Stock
- -   MATEON THERAPEUTICS INC 4 - --I 1200504.0000 3 0000908259 Common Stock
- -   Oncotelic Therapeutics, Inc. 4 - --I 16780384.0000 2 0000908259 Common Stock
- -   Oncotelic Therapeutics, Inc. 4 - --I 6872529.0000 3 0000908259 Common Stock
- -   Oncotelic Therapeutics, Inc. 4 - --I 16780384.0000 2 0000908259 Common Stock

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016